Energy-requiring uptake of prostasomes and PC3 cell-derived exosomes into non-malignant and malignant cells

References

• Ronquist G, Hedstrom M. Restoration of detergent-inactivated adenosine triphosphatase activity of human prostatic fluid with concanavalin A. Biochim Biophys Acta. 1977; 483: 483–6.
   PubMed Web of Science ®Google Scholar
• Ronquist G. Prostasomes are mediators of intercellular communication: from basic research to clinical implications. J Intern Med. 2012; 271: 400–13.
   PubMed Web of Science ®Google Scholar
• Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta. 1985; 822: 203–18.
   PubMed Web of Science ®Google Scholar
• Sahlen GE, Egevad L, Ahlander A, Norlen BJ, Ronquist G, Nilsson BO. Ultrastructure of the secretion of prostasomes from benign and malignant epithelial cells in the prostate. Prostate. 2002; 53: 192–9.
   PubMed Web of Science ®Google Scholar
• Park KH, Kim BJ, Kang J, Nam TS, Lim JM, Kim HT, etal. Ca2+ signaling tools acquired from prostasomes are required for progesterone-induced sperm motility. Sci Signal. 2011; 4: ra31.
   PubMed Web of Science ®Google Scholar
• Ronquist GK, Larsson A, Ronquist G, Isaksson A, Hreinsson J, Carlsson L, etal. Prostasomal DNA characterization and transfer into human sperm. Mol Reprod Dev. 2011; 78: 467–76.
   Web of Science ®Google Scholar
• Ronquist GK, Larsson A, Stavreus-Evers A, Ronquist G. Prostasomes are heterogeneous regarding size and appearance but affiliated to one DNA-containing exosome family. Prostate. 2012; 72: 1736–45.
   Web of Science ®Google Scholar
• Aalberts M, van Dissel-Emiliani FM, van Adrichem NP, van Wijnen M, Wauben MH, Stout TA, etal. Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol Reprod. 2012; 86: 82.
   PubMed Web of Science ®Google Scholar
• Llorente A, de Marco MC, Alonso MA. Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. J Cell Sci. 2004; 117(Pt 22): 5343–51.
   PubMed Web of Science ®Google Scholar
• Ronquist KG, Carlsson L, Ronquist G, Nilsson S, Larsson A. Prostasome-derived proteins capable of eliciting an immune response in prostate cancer patients. Int J Cancer. 2006; 119: 847–53.
   PubMed Web of Science ®Google Scholar
• Dubois L, Ronquist KG, Ek B, Ronquist G, Larsson A. Proteomic profiling of detergent resistant membranes (lipid rafts) of prostasomes. Mol Cell Proteomics. 2015; 14: 3015–22.
   Web of Science ®Google Scholar
• Arvidson G, Ronquist G, Wikander G, Ojteg AC. Human prostasome membranes exhibit very high cholesterol/phospholipid ratios yielding high molecular ordering. Biochim Biophys Acta. 1989; 984: 167–73.
   PubMed Web of Science ®Google Scholar
• Brouwers JF, Aalberts M, Jansen JW, van Niel G, Wauben MH, Stout TA, etal. Distinct lipid compositions of two types of human prostasomes. Proteomics. 2013; 13: 1660–6.
   Web of Science ®Google Scholar
• Ronquist KG, Ek B, Morrell J, Stavreus-Evers A, Strom Holst B, Humblot P, etal. Prostasomes from four different species are able to produce extracellular adenosine triphosphate (ATP). Biochim Biophys Acta. 2013; 1830: 4604–10.
   Web of Science ®Google Scholar
• Drake RR, Kislinger T. The proteomics of prostate cancer exosomes. Expert Rev Proteomics. 2014; 11: 167–77.
   PubMedGoogle Scholar
• Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, etal. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget. 2015; 6: 21740–54.
   PubMed Web of Science ®Google Scholar
• Webber JP, Spary LK, Sanders AJ, Chowdhury R, Jiang WG, Steadman R, etal. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene. 2015; 34: 290–302.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011; 11: 85–95.
   PubMed Web of Science ®Google Scholar
• Ronquist KG, Ek B, Stavreus-Evers A, Larsson A, Ronquist G. Human prostasomes express glycolytic enzymes with capacity for ATP production. Am J Physiol Endocrinol Metab. 2013; 304: E576–82.
   Web of Science ®Google Scholar
• Mathivanan S, Simpson RJ. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics. 2009; 9: 4997–5000.
   PubMed Web of Science ®Google Scholar
• Ronquist G. Zinc ion stimulation of ATP cleavage by prostasomes from human seminal plasma. Urol Int. 1988; 43: 334–40.
   PubMed Web of Science ®Google Scholar
• Ronquist G. Effect of modulators on prostasome membrane-bound ATPase in human seminal plasma. Eur J Clin Invest. 1987; 17: 231–6.
   PubMed Web of Science ®Google Scholar
• Nilsson BO, Jin M, Einarsson B, Persson BE, Ronquist G. Monoclonal antibodies against human prostasomes. Prostate. 1998; 35: 178–84.
   PubMed Web of Science ®Google Scholar
• Harma V, Virtanen J, Makela R, Happonen A, Mpindi JP, Knuuttila M, etal. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One. 2010; 5: e10431.
   PubMed Web of Science ®Google Scholar
• Nyga A, Cheema U, Loizidou M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal. 2011; 5: 239–48.
   PubMed Web of Science ®Google Scholar
• Dubois L, Stridsberg M, Kharaziha P, Chioureas D, Meersman N, Panaretakis T, etal. Malignant cell-derived extracellular vesicles express different chromogranin epitopes compared to prostasomes. Prostate. 2015; 75: 1063–73.
   PubMed Web of Science ®Google Scholar
• Pankiewicz KW. Novel nicotinamide adenine dinucleotide analogues as potential anticancer agents: quest for specific inhibition of inosine monophosphate dehydrogenase. Pharmacol Ther. 1997; 76: 89–100.
   PubMed Web of Science ®Google Scholar
• Floryk D, Tollaksen SL, Giometti CS, Huberman E. Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5’-monophosphate dehydrogenase. Cancer Res. 2004; 64: 9049–56.
   Web of Science ®Google Scholar
• Agren G, Ponten J, Ronquist G, Westermark B. Demonstration of an ATPase at the cell surface of intact normal and neoplastic human cells in culture. J Cell Physiol. 1971; 78: 171–6.
   PubMed Web of Science ®Google Scholar
• Hattori M, Gouaux E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature. 2012; 485: 207–12.
   PubMed Web of Science ®Google Scholar
• Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem. 1991; 266: 17707–12.
   PubMed Web of Science ®Google Scholar
• Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M, etal. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011; 124(Pt 3): 447–58.
   PubMed Web of Science ®Google Scholar
• Stegmayr B, Brody I, Ronquist G. A biochemical and ultrastructural study on the endogenous protein kinase activity of secretory granule membranes of prostatic origin in human seminal plasma. J Ultrastruct Res. 1982; 78: 206–14.
   PubMedGoogle Scholar
• Agren G, Ronquist G. (32-P) Phosphoryl transfer by endogenous protein kinase at the glia and glioma cell surface in culture into extrinsic acceptor proteins. Acta physiol Scand. 1974; 92: 430–2.
   Google Scholar
• Boyce AK, Kim MS, Wicki-Stordeur LE, Swayne LA. ATP stimulates pannexin 1 internalization to endosomal compartments. Biochem J. 2015; 470: 319–30.
   Web of Science ®Google Scholar
• White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci. 2006; 27: 211–7.
   PubMed Web of Science ®Google Scholar
• Roger S, Pelegrin P. P2X7 receptor antagonism in the treatment of cancers. Expert Opin Investig Drugs. 2011; 20: 875–80.
   PubMed Web of Science ®Google Scholar